Latest Cash Flow News

Medallion Metals has completed a pivotal feasibility study for its Ravensthorpe Gold Project and raised $60 million to accelerate development, while progressing a key acquisition of Forrestania assets.

AdNeo Limited reported a striking 89% increase in customer receipts in Q2 FY26, driven by recent acquisitions and strong contract wins, edging close to cash flow positivity. The company’s strategic cost reductions and expanding sales pipeline signal promising momentum for the remainder of the year.

Peninsula Energy reported a $9.6 million operating cash outflow for the December 2025 quarter but maintains a strong cash position of $31.8 million, supported by a $12.6 million refinancing deal. The company anticipates uranium sales from its Lance Project to improve cash flows in coming quarters.

XPON Technologies Group delivered a robust Q1 FY26 with an 8.3% revenue increase and positive operating cash flow, underpinned by successful Alpha Digital integration and strong recurring revenue.

Noumi Limited reported a 13.4% revenue increase in Q2 FY26 driven by strong growth in its Dairy and Nutritionals and Plant-based Milks segments, despite a $4.5 million operating cash outflow impacted by legal expenses. The company’s Milklab brand continues to gain traction both domestically and internationally.

archTIS Limited reports a remarkable 308% increase in annual recurring revenue, driven by deepening ties with the U.S. Department of Defense and strategic Spirion acquisition integration.

Horizon Minerals Ltd reported a solid quarterly cash flow increase of A$3.1 million, ending December 2025 with A$37.5 million in cash and equivalents. The company also extinguished its Nebari Convertible Loan Facility, signaling a cleaner capital structure ahead.

QMines Limited has made significant strides in its Queensland projects with high-grade drilling results at Mount Mackenzie and Develin Creek, backed by a $9 million capital raise to support exploration and development.

Nutritional Growth Solutions reports improved cash flow and cost savings amid leadership changes, setting the stage for renewed growth in FY26.

Imugene Limited has reported compelling clinical trial results for its off-the-shelf CAR T therapy, azer-cel, alongside FDA validation and a strategic collaboration, while managing cash flow amid cost reductions.

Green360 Technologies has made significant strides in commercialising its low-carbon cement product Eco-Clay, delivering successful large-scale trials and securing a robust financial footing heading into 2026.

FortifAI Limited has acquired FastAI and its cutting-edge Nol8 Technology, driving a 14.7% revenue increase and delivering positive net operating cash flow for the first time in Q2 FY26.